Nov 8 (Reuters) - Ambu A/S AMBUb.CO :
* ANNUAL REPORT
* ENDOSCOPY SOLUTIONS REVENUE INCREASED ORGANICALLY BY 23%
(0%)
AND BY 12% (0%) YEAR-TO-DATE
* ENDOSCOPY SOLUTIONS EXCLUDING PULMONOLOGY INCREASED BY 33%
* IN Q3, AMBU PROGRESSED TO ACHIEVE OPTIMAL NET WORKING
CAPITAL
AND INVENTORY PERFORMANCE
* AMBU UPGRADED ITS FULL-YEAR EBIT MARGIN BEFORE SPECIAL
ITEMS TO
5-6% (PREVIOUSLY 3-5%), MAINLY DRIVEN BY A BETTER-THAN-EXPECTED
GROSS MARGIN, DUE TO A STRENGTHENED PRODUCT MIX
Source text for Eikon: ID:nGNE3WM13f
Further company coverage: AMBUb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))